The Cheapest Time to Fix a Medical Device Is Before You Build It
Every medical device carries a cost curve that most teams discover the hard way. A design choice that costs almost nothing to change on a whiteboard can cost a fortune to change after tooling is cut, validation is run, and the first units are in a sterilization load. By the time a problem surfaces in production — or worse, in a customer complaint — the bill includes scrap, rework, re-validation, and the one thing no schedule can recover: time.
This is why design for manufacturability (DFM) is not a late-stage manufacturing concern. It is a decision you make at the very front of development, when you translate customer needs into design inputs. Get that translation right and the rest of the program gets easier. Get it wrong and you spend the next eighteen months paying interest on a debt you took on during a single design review.
Figure 1 — The cost to correct a design problem rises by orders of magnitude across the development lifecycle.
Design inputs are where manufacturability is won or lost
A requirement that reads well on paper can be nearly impossible to build repeatably. Tolerances that look reasonable in isolation can stack into a part that only a hero on the line can assemble. The discipline that prevents this is unglamorous: understand what the customer actually needs, write design inputs that capture it without over-constraining the design, and pressure-test every output against how it will be made, inspected, and packaged at volume.
When that discipline holds, iteration cycles shrink. Labeling, fixtures, and test methods get designed alongside the product rather than bolted on afterward. Verification and validation are planned on a risk basis, so you test what matters at a sample size you can defend to an auditor — not everything, everywhere, at maximum cost.
What good looks like
On one engagement supporting a surgical and implantable device company, the goal was to launch a slate of new products — hemostats, adhesion barriers, orthobiologics, tissue-based devices — without disrupting supply and while reducing cost. That combination is only possible when manufacturability is engineered in from the start: requirements traced end to end, internal processes optimized for throughput, and design verification structured around risk-based sample sizes and large-scale process validation. The result was a seamless launch that also eliminated long-standing customer complaints rooted in the previous design.
The takeaway for device teams
Treat manufacturability as a design input, not a manufacturing afterthought. Bring process, quality, and supply perspectives into early design reviews. Make your design reviews clear and concise enough that a future auditor — or a future engineer who inherits the file — can follow the logic without you in the room. The teams that do this consistently spend less, launch faster, and field fewer complaints. The cheapest time to fix a device really is before you build it.
LET’S TALK Planning a new device or a redesign? MEDEVEX helps teams engineer manufacturability in from the first design review. Let’s talk about your next launch.